Ready. Raise. Rise. Campaign
- Details
- Category: Bristol-Myers Squibb
The Ready. Raise. Rise. campaign encourages everyone to raise and share a flag to salute those who have been touched by cancer, especially patients and caregivers, and learn more about a rapidly evolving area of research, Immuno-Oncology, which seeks to harness the body's own immune system to fight cancer.
Pfizer reports first-quarter 2016 results
- Details
- Category: Pfizer
Pfizer Inc. (NYSE: PFE) reported financial results for first-quarter 2016 and updated certain components of its 2016 financial guidance. Reported revenues totaled $13.0 billion, an increase of $2.1 billion, or 20%, which reflects operational growth of $2.9 billion, or 26%, partially offset by the unfavorable impact of foreign exchange of $729 million, or 7%.
Bristol-Myers Squibb reports first quarter financial results
- Details
- Category: Bristol-Myers Squibb
Bristol-Myers Squibb Company (NYSE:BMY) today reported results for the first quarter of 2016, which were highlighted by strong sales for Opdivo, Eliquis and our hepatitis C franchise along with significant regulatory milestones and key data in Immuno-Oncology.
One family's history of the rare condition Fabry disease through the generations
- Details
- Category: Shire
In recognition of International Fabry Awareness month, Shire has released the trailer for Our Fabry Family Tree, a short film series featuring a family who were unknowingly affected by Fabry disease for generations before genetic analysis shed light on a diagnosis of the rare condition.
What's the secret to living a full life? A new global survey reveals family comes first
- Details
- Category: Abbott
If you have ever asked yourself, "What makes me feel most fulfilled?" you are not alone. Nearly 2 million people recently answered that question in a new survey by Abbott, the global healthcare company.
Bayer off to a successful start in 2016
- Details
- Category: Bayer
The Bayer Group got off to a successful start in the new fiscal year. "All segments posted gains in their operating performance," said CEO Dr. Marijn Dekkers when he presented the interim report for the first quarter on Tuesday. At Pharmaceuticals, Bayer again benefited from the very good development of its recently launched products.
Merck brings international start-up-companies to Darmstadt and Nairobi
- Details
- Category: Merck Group
Merck, a leading science and technology company, has announced the participants for its Accelerator Programs in Darmstadt and Nairobi. Almost 200 highly competitive applications from 47 countries were submitted for consideration.
More Pharma News ...
- 2016 Otto Bayer Award goes to Professor Dr. Dirk Trauner
- AstraZeneca launches integrated genomics approach to transform drug discovery and development
- Novartis delivered solid Q1 despite Gleevec loss of exclusivity
- Roche reports solid sales growth in the first quarter of 2016
- FDA grants priority review for Roche's cancer immunotherapy atezolizumab in specific type of lung cancer
- New analysis shows only minority of COPD patients may benefit from inhaled corticosteroids
- AstraZeneca and Eli Lilly and Company announce continuation of pivotal clinical trial for people with early Alzheimer's disease